The Norwegian Radium Hospital, The Research Building
CCB's principal investigator Prof. Kirsten Sandvig recently received a new grant for work with biodegradable nanoparticles through INNO INDIGO which is an innovation-driven initiative for the development and integration of Indian and European research.
CCB congratulates Guro Elisabeth Lind with a two-year Principal Investigator position for the period 2016-2017.
In December six research prizes were awarded to scientists from Oslo University Hospital. CCBs Marina Vietri and Camilla Raiborg were among the prize winners. Both Vietri and Raiborg are members of Harald Stenmark's group at the Department of Biochemistry, Institute for Cancer Research, Oslo University Hospital.
PhD student Tor Espen Thorvaldsen, together with postdoc Nina Marie Pedersen and their co-workers in Harald Stenmark's group at Institute for Cancer Research and Centre for Cancer Biomedicine, have published a cover story in the November 2015 issue of Molecular Cancer Research.
The 2015 "Dr. Ragnar Mørk's legacy prize" went to Guro E. Lind, head of the Epigenetics Group at the Department of Molecular Oncology, Oslo University Hospital, and Centre for Cancer Biomedicine, University of Oslo.